Pharmaceutical Technology on MSN
Health Canada approves Biogen’s Zurzuvae for PPD treatment
Zurzuvae was generally well-tolerated, with the most common side effects being sedation, somnolence and dizziness.
April 22 (Reuters) - Shares of Pharmaceutical Product Development Inc (PPD) fell as much as 18 percent to a four-year low Wednesday, a day after the clinical-research service provider lowered its full ...
Jan 14 (Reuters) - Pharmaceutical Product Development Inc , a large contract research company, forecast 2009 earnings above market estimates, and said it expects three milestone payments from its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback